日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intermittent catheterisation: individuals' rights, accessibility, and environmental concerns

间歇性导尿:个人权利、可及性和环境问题

Krassioukov, Andrei; Wyndaele, Michel; Walter, Matthias; Keppenne, Veronique; Welk, Blayne; Vrijens, Desiree; Theron, Francois

Intermittent catheterization: A patient-centric approach is key to optimal management of neurogenic lower urinary tract dysfunction

间歇性导尿:以患者为中心的治疗方法是优化神经源性下尿路功能障碍管理的关键

Krassioukov, Andrei; Welk, Blayne; Vrijens, Desiree; Islamoska, Sabrina; Barken, Kim Bundvig; Keppenne, Veronique; Wyndaele, Michel; Walter, Matthias

Low-dose onabotulinumtoxinA improves urinary symptoms in noncatheterizing patients with MS

低剂量A型肉毒杆菌毒素可改善非导尿型多发性硬化症患者的泌尿系统症状。

Tullman, Mark; Chartier-Kastler, Emmanuel; Kohan, Alfred; Keppenne, Veronique; Brucker, Benjamin M; Egerdie, Blair; Mandle, Meryl; Nicandro, Jean Paul; Jenkins, Brenda; Denys, Pierre

Erratum to: OnabotulinumtoxinA is Effective in Patients with Urinary Incontinence due to Neurogenic Detrusor Overactivity Regardless of Concomitant Anticholinergic Use or Neurologic Etiology

更正:无论是否同时使用抗胆碱能药物或是否存在神经系统病因,A型肉毒杆菌毒素对神经源性逼尿肌过度活动引起的尿失禁患者均有效

Holt, Bronte A; Varadarajulu, Shyam; Hébert-Magee, Shantel; Ginsberg, David; Cruz, Francisco; Herschorn, Sender; Gousse, Angelo; Keppenne, Véronique; Aliotta, Philip; Sievert, Karl-Dietrich; Brin, Mitchell F; Jenkins, Brenda; Thompson, Catherine; Lam, Wayne; Heesakkers, John; Haag-Molkenteller, Cornelia

OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology

无论是否同时使用抗胆碱能药物或是否存在神经系统病因,A型肉毒杆菌毒素对因神经源性逼尿肌过度活动引起的尿失禁患者均有效[已更正]。

Ginsberg, David; Cruz, Francisco; Herschorn, Sender; Gousse, Angelo; Keppenne, Véronique; Aliotta, Philip; Sievert, Karl-Dietrich; Brin, Mitchell F; Jenkins, Brenda; Thompson, Catherine; Lam, Wayne; Heesakkers, John; Haag-Molkenteller, Cornelia